Early Access — free while we kick the tires
EdgarHawk

Mercer Patrick

President and CEO

Officer
2 filings analyzed · 1 company · Latest 2025-06-13

Never miss a filing from Mercer Patrick

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
IRIDEX CORP IRIX 2 0 Net buying

Activity

June 2025
2025-06-13 IRIDEX CORP IRIX
low
Buy
250 shares
$240
Significance 3/10

Mercer Patrick (CEO) bought 250 shares of IRIX at $0.96 on 2025-06-13; stock down 57.5% from 52-week high and trading below buy price.

Mercer Patrick, President and CEO, purchased 250 shares at $0.96 on 2025-06-13, adding to holdings of 386.7K shares. The stock currently trades at $0.94, below the transaction price, and has declined 57.5% from its 52-week high of $2.21. IRIDEX is unprofitable (net income $-1.7M on quarterly revenue of $11.9M) and posted -6.2% annual revenue growth. Patrick's prior IRIX purchases at this ticker have not delivered positive 90-day returns: three earlier buys on 2025-04-28 and 2025-04-24 each showed negative 30-day performance (-27.1%, -26.5%, and -14.8% respectively), with 90-day outcomes not yet measurable. A cluster pattern is present—two other insiders also bought within the past 14 days. The transaction itself is modest in size (250 shares, $240 total value) and raises questions given the poor price timing on prior accumulation, the company's declining revenue and unprofitability, and the stock's sustained weakness relative to recent history.

April 2025
2025-04-28 IRIDEX CORP IRIX
high
Buy
7,546 shares
$9,758
Significance 6/10

CEO Mercer Patrick acquired 7,546 shares across 3 transactions for $9,757.90; 4 other insiders also bought within 14 days at IRIX.

Mercer Patrick, President and CEO, executed 3 separate purchases totaling 7,546 shares for $9,757.90 with a blended average price of $1.29, increasing his holdings by 1.9% to 400,790 shares post-transaction. The purchases occurred on 2025-04-24 and 2025-04-28, within a period where 4 other insiders also bought—a cluster buy pattern. IRIX trades at $1.30 (current price), down 58.2% from its 52-week high of $3.11 yet up 30.1% over the past 30 days. The company reported quarterly revenue of $11,581,000.00 with a net loss of $-1,933,000.00 and negative full-year net income, alongside 6.2% annual revenue decline. The combination of coordinated insider accumulation at reduced valuations during a period of operational losses and near-52-week lows merits close observation of management's conviction and forward-looking visibility.

Related insiders